Five Prime Therapeutics, Inc. Revenue
Five Prime Therapeutics, Inc. reported Revenue of $13.18 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-03-22
- Five Prime Therapeutics, Inc. revenues for the quarter ending 2020-12-31 was -$708.00K, a 122.06% decline year-over-year.
- Five Prime Therapeutics, Inc. revenues for the quarter ending 2020-09-30 was $2.05M, a 31.37% decline year-over-year.
- Five Prime Therapeutics, Inc. revenues for the quarter ending 2020-06-30 was $3.42M, a 2.73% increase year-over-year.
- Five Prime Therapeutics, Inc. revenues for the quarter ending 2020-03-31 was $8.41M, a 57.36% increase year-over-year.
- Five Prime Therapeutics, Inc. revenues for fiscal 2020 was $13.18M, a 11.40% decline from fiscal 2019.
- Five Prime Therapeutics, Inc. revenues for fiscal 2019 was $14.87M, a 70.17% decline from fiscal 2018.
- Five Prime Therapeutics, Inc. revenues for fiscal 2018 was $49.87M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$708.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $1.34M derived: sum of 2 quarters · filed 2021-03-22 | $4.76M derived: sum of 3 quarters · filed 2021-03-22 | $13.18M 10-K · filed 2021-03-22 |
| 2020-09-30 | $2.05M 10-Q · filed 2020-11-03 | $5.47M derived: sum of 2 quarters · filed 2020-11-03 | $13.89M 10-Q · filed 2020-11-03 | $17.10M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-06-30 | $3.42M 10-Q · filed 2020-08-06 | $11.84M 10-Q · filed 2020-08-06 | $15.05M derived: sum of 3 quarters · filed 2021-03-22 | $18.03M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | $8.41M 10-Q · filed 2020-05-07 | $11.62M derived: sum of 2 quarters · filed 2021-03-22 | $14.61M derived: sum of 3 quarters · filed 2021-03-22 | $17.94M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $6.19M derived: sum of 2 quarters · filed 2021-03-22 | $9.53M derived: sum of 3 quarters · filed 2021-03-22 | $14.87M 10-K · filed 2021-03-22 |
| 2019-09-30 | $2.98M 10-Q · filed 2020-11-03 | $6.32M derived: sum of 2 quarters · filed 2020-11-03 | $11.66M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $3.33M 10-Q · filed 2020-08-06 | $8.68M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $5.35M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $49.87M 10-K · filed 2021-03-22 | |||
| 2017-12-31 | $13.22M 10-K · filed 2018-02-27 | $21.55M derived: sum of 2 quarters · filed 2018-02-27 | $29.37M derived: sum of 3 quarters · filed 2018-02-27 | $39.51M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-09-30 | $8.33M 10-K · filed 2018-02-27 | $16.16M derived: sum of 2 quarters · filed 2018-02-27 | $26.29M derived: sum of 3 quarters · filed 2018-02-27 | $34.55M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | $7.82M 10-K · filed 2018-02-27 | $17.96M derived: sum of 2 quarters · filed 2018-02-27 | $26.22M derived: sum of 3 quarters · filed 2018-02-27 | $32.90M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | $10.13M 10-K · filed 2018-02-27 | $18.40M derived: sum of 2 quarters · filed 2018-02-27 | $25.08M derived: sum of 3 quarters · filed 2018-02-27 | $34.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | $8.26M 10-K · filed 2018-02-27 | $14.94M derived: sum of 2 quarters · filed 2018-02-27 | $24.17M derived: sum of 3 quarters · filed 2018-02-27 | $30.69M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-09-30 | $6.68M 10-K · filed 2018-02-27 | $15.91M derived: sum of 2 quarters · filed 2018-02-27 | $22.43M derived: sum of 3 quarters · filed 2018-02-27 | $385.77M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $9.23M 10-K · filed 2018-02-27 | $15.75M derived: sum of 2 quarters · filed 2018-02-27 | $379.09M derived: sum of 3 quarters · filed 2018-02-27 | $384.95M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $6.52M 10-K · filed 2018-02-27 | $369.86M derived: sum of 2 quarters · filed 2018-02-27 | $375.72M derived: sum of 3 quarters · filed 2018-02-27 | $382.03M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $363.34M 10-K · filed 2017-02-24 | $369.20M derived: sum of 2 quarters · filed 2017-02-24 | $375.51M derived: sum of 3 quarters · filed 2017-02-24 | $379.80M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-09-30 | $5.86M 10-K · filed 2017-02-24 | $12.17M derived: sum of 2 quarters · filed 2017-02-24 | $16.46M derived: sum of 3 quarters · filed 2017-02-24 | $21.11M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $6.32M 10-K · filed 2017-02-24 | $10.60M derived: sum of 2 quarters · filed 2017-02-24 | $15.25M derived: sum of 3 quarters · filed 2017-02-24 | $21.31M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $4.29M 10-K · filed 2017-02-24 | $8.93M derived: sum of 2 quarters · filed 2017-02-24 | $14.99M derived: sum of 3 quarters · filed 2017-02-24 | $19.97M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $4.64M 10-K · filed 2016-03-11 | $10.70M derived: sum of 2 quarters · filed 2016-03-11 | $15.69M derived: sum of 3 quarters · filed 2016-03-11 | $19.23M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-09-30 | $6.06M 10-K · filed 2016-03-11 | $11.04M derived: sum of 2 quarters · filed 2016-03-11 | $14.59M derived: sum of 3 quarters · filed 2016-03-11 | $18.37M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $4.98M 10-K · filed 2016-03-11 | $8.53M derived: sum of 2 quarters · filed 2016-03-11 | $12.31M derived: sum of 3 quarters · filed 2016-03-11 | $15.79M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $3.55M 10-K · filed 2016-03-11 | $7.33M derived: sum of 2 quarters · filed 2016-03-11 | $10.81M derived: sum of 3 quarters · filed 2016-03-11 | $14.36M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $3.79M 10-K · filed 2015-03-18 | $7.27M derived: sum of 2 quarters · filed 2015-03-18 | $10.82M derived: sum of 3 quarters · filed 2015-03-18 | $13.79M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-09-30 | $3.48M 10-K · filed 2015-03-18 | $7.03M derived: sum of 2 quarters · filed 2015-03-18 | $10.01M derived: sum of 3 quarters · filed 2015-03-18 | $12.93M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $3.55M 10-K · filed 2015-03-18 | $6.52M derived: sum of 2 quarters · filed 2015-03-18 | $9.45M derived: sum of 3 quarters · filed 2015-03-18 | $12.31M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $2.98M 10-K · filed 2015-03-18 | $5.90M derived: sum of 2 quarters · filed 2015-03-18 | $8.76M derived: sum of 3 quarters · filed 2015-03-18 | $10.94M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $2.92M 10-K · filed 2014-03-26 | $5.79M derived: sum of 2 quarters · filed 2014-03-26 | $7.97M derived: sum of 3 quarters · filed 2014-03-26 | $9.98M derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-09-30 | $2.86M 10-K · filed 2014-03-26 | $5.04M derived: sum of 2 quarters · filed 2014-03-26 | $7.06M derived: sum of 3 quarters · filed 2014-03-26 | |
| 2012-06-30 | $2.18M 10-K · filed 2014-03-26 | $4.20M derived: sum of 2 quarters · filed 2014-03-26 | ||
| 2012-03-31 | $2.01M 10-K · filed 2014-03-26 |